Biogen (BIIB) Operating Income (2009 - 2026)
Biogen (BIIB) reported Operating Income of -$644.5 million for Q2 2026, compared with $139 million a year earlier.
Powered by 
Analysis
Biogen (BIIB) Operating Income (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Biogen's Operating Income came in at -$1.6 billion; for FY2025, it came in at -$847.7 million.
- By year, Operating Income came in at -$404.4 million in FY2024, -$1.24 billion in FY2023, $1.31 billion in FY2022 (-53.8%) and $2.84 billion in FY2021 (-37.6%).
- The Q2 2026 figure ranks as the lowest quarterly Operating Income since Q3 2023.
- The high point for year-over-year Operating Income in five years was Q2 2022 (growth of 61.7%); the low point was Q4 2022 (a decline of 94.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at -$283.3 million (Q1 2026), -$551.5 million (Q4 2025) and -$117.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Biogen | 37.51 Bn | 24.16 Bn | 1.96 Bn | -644.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -644.50 Mn |
| Mar 31, 2026 | -283.30 Mn |
| Dec 31, 2025 | -551.50 Mn |
| Sep 30, 2025 | -117.10 Mn |
| Jun 30, 2025 | 139.00 Mn |
| Mar 31, 2025 | -318.10 Mn |
| Dec 31, 2024 | -292.00 Mn |
| Sep 30, 2024 | -187.70 Mn |
| Jun 30, 2024 | 152.70 Mn |
| Mar 31, 2024 | -77.40 Mn |
| Dec 31, 2023 | -326.70 Mn |
| Sep 30, 2023 | -800.80 Mn |
| Jun 30, 2023 | 115.40 Mn |
| Mar 31, 2023 | -224.50 Mn |
| Dec 31, 2022 | 32.90 Mn |
| Sep 30, 2022 | 901.60 Mn |
| Jun 30, 2022 | 785.50 Mn |
| Mar 31, 2022 | 610.70 Mn |
| Dec 31, 2021 | 587.10 Mn |
| Sep 30, 2021 | 794.00 Mn |
API Access
Biogen Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();